{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:04:32Z","timestamp":1770221072878,"version":"3.49.0"},"reference-count":27,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T00:00:00Z","timestamp":1363651200000},"content-version":"vor","delay-in-days":9088,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1988,5]]},"abstract":"<jats:p>The effect of 6% hydroxyethyl starch (hetastarch) and 5% human serum albumin (albumin) infusion on coagulation in 12 patients with septic shock was evaluated. Patients were randomly assigned to receive either albumin (N = 6) or hetastarch (N = 6) infusion over a 24\u2010hour study interval. The prothrombin time (PT), partial thromboplastin time (PTT), and quantitative platelet count (PC) were obtained prior to and following 24 hours of fluid infusion. Hetastarch patients received 4934 \u00b1 1354 mL and albumin patients received 3067 \u00b1 256 mL over the study interval. After hetastarch infusion, the PT increased 2.2 \u00b1 0.7 seconds, PTT increased 20.0 \u00b1 4.1 seconds (P &lt; .01), and PC decreased 158 \u00b1 36 \u00d7 10<jats:sup>3<\/jats:sup>\/mm<jats:sup>3<\/jats:sup> (P &lt; .02). After albumin administration, the PT decreased 1.2 \u00b1 1.7 seconds, PTT increased 20.5 \u00b1 10.6 seconds and PC decreased 100 \u00b1 34 \u00d7 10<jats:sup>3<\/jats:sup>\/mm<jats:sup>3<\/jats:sup>. There were no significant differences in the changes in PT, PTT, or PC between the groups. The authors conclude that hetastarch infusion does not result in increased bleeding in patients with septic shock compared with albumin infusion, despite moderate effects on the hemostatic coagulation profile.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1988.tb05751.x","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T15:31:11Z","timestamp":1363707071000},"page":"412-415","source":"Crossref","is-referenced-by-count":47,"title":["Effects of Hetastarch and Albumin on Coagulation in Patients with Septic Shock"],"prefix":"10.1002","volume":"28","author":[{"given":"Jay L.","family":"Falk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric C.","family":"Rackow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Astiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max Harry","family":"Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,19]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(51)90113-1"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-197901000-00003"},{"key":"e_1_2_1_4_2","first-page":"679","article-title":"Hemodynamic effectiveness of colloid and electrolyte solutions for replacement of simulated operative blood loss","volume":"131","author":"Carey JS","year":"1970","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198101000-00006"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198101000-00010"},{"key":"e_1_2_1_7_2","first-page":"1203","article-title":"The bleeding tendency associated with plasma expanders","volume":"124","author":"Gollub S","year":"1967","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198307000-00007"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198311000-00001"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-196709000-00013"},{"key":"e_1_2_1_11_2","first-page":"1235","article-title":"A study of safer plasma substitutes","volume":"128","author":"Gollub S","year":"1969","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(10)60907-1"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(10)61949-2"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(10)60683-2"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(10)60756-4"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(10)60707-2"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-5223(19)38727-6","article-title":"A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass","volume":"89","author":"Sade RM","year":"1985","journal-title":"J Thorac Cardiovasc Surg"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-5223(19)39512-1","article-title":"Hydroxyethyl starch in priming fluid for cardiopulmonary bypass","volume":"84","author":"Sade RM","year":"1982","journal-title":"J Thorac Cardiovasc Surg"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(10)60908-3"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1983.01390070016004"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-196805000-00005"},{"key":"e_1_2_1_22_2","first-page":"460","article-title":"The effect of hydroxyethyl starch on the intra\u2010 and postoperative behavior of haemostasis","volume":"16","author":"Muller N","year":"1977","journal-title":"Bibl Anat"},{"key":"e_1_2_1_23_2","first-page":"322","article-title":"Comparable studies of the behavior of the plasmic coagulation, the fibrinolysis as well as the platelets under application of dextran or hydroxyethyl starch","volume":"16","author":"Popov\u2010Cenic S","year":"1977","journal-title":"Bibl Anat"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5621.783"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1985.25485273815.x"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1985.25385219903.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1985.25385219904.x"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1981.21381201801.x"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1988.tb05751.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1988.tb05751.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T03:17:21Z","timestamp":1697858241000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1988.tb05751.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1988,5]]}},"alternative-id":["10.1002\/j.1552-4604.1988.tb05751.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1988.tb05751.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,5]]}}}